ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO)

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 53,136,600
Number of holders: 85
Total 13F shares, excl. options: 30,524,457
Shares change: +4,428,180
Total reported value, excl. options: $2,626,526,882
Value change: +$420,173,605
Put/Call ratio: 71.45%
Number of buys: 65
Number of sells: -17
Price: $86.2

Significant Holders of ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO) as of Q4 2020

96 filings reported holding ALXO - ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share as of Q4 2020.
ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO) has 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 30,524,457 shares of 53,136,600 outstanding shares and own 57.45% of the company stock.
Largest 10 shareholders include venBio Partners LLC (9,699,925 shares), Vivo Capital, LLC (4,220,048 shares), Logos Global Management LP (3,156,981 shares), WELLINGTON MANAGEMENT GROUP LLP (1,983,106 shares), JANUS HENDERSON GROUP PLC (1,628,199 shares), BlackRock Inc. (1,372,749 shares), FMR LLC (1,068,499 shares), Foresite Capital Management IV, LLC (973,514 shares), Redmile Group, LLC (960,400 shares), and VANGUARD GROUP INC (883,262 shares).
This table shows the top 85 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.